Insulet said its Omnipod 5 Automated Insulin Delivery (AID) System is now available in Australia and will soon be offered in three additional countries.
- Omnipod 5 is now commercially available in Australia with Dexcom G6 and G7 compatibility, with plans underway to soon add Abbott’s FreeStyle Libre 2 Plus.
- Omnipod 5 will be accessible in Belgium in the coming weeks, with Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 and G7 sensor integrations.
- Omnipod 5 will next launch in Canada later this spring with Dexcom G6 and G7 compatibility.
- Omnipod 5 will also be offered in Switzerland, also later this spring, with Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 and G7 sensor integrations.
Insulet also recently expanded sensor integrations to include Dexcom G7 for Omnipod 5 users in the U.K. and the Netherlands. Additionally, Insulet is planning to bring Omnipod 5 to five more markets including Israel, Saudi Arabia, the United Arab Emirates, Qatar, and Kuwait. Timing will be shared in the coming months.
The Omnipod 5 System simplifies diabetes management and has shown to improve clinical outcomes by eliminating the need for multiple daily injections (MDI) and automatically adjusting insulin delivery every five minutes using its advanced SmartAdjust technology. The waterproof and wearable Omnipod 5 is the first tubeless AID system that communicates with a continuous glucose monitor, proactively correcting for highs and helping to protect against lows, day and night.
This news follows Insulet’s announcement in January about Omnipod 5 launches Italy and the Nordics that were enthusiastically received by customers and healthcare providers, which followed equally successful launches in the U.S., U.K., Germany, France, and the Netherlands.
